Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining

NCT02486497 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: hENT1

Sponsor

Seoul National University Hospital

Collaborators

[object Object]